Former National Retail Federation executive joins FMI
ARLINGTON, Va. The Food Marketing Institute last week appointed a new VP industry relations.
Rhett Asher joined FMI from the National Retail Federation, where he served as VP loss prevention. Asher served in a similar capacity at the Retail Industry Leaders Association from 2003 to 2006. He will be responsible for enhancing the capabilities and services of industry relations at FMI, specifically the FMI/GMA Trading Partner Alliance. He also will support other programs, including loss prevention and risk management, technology, and marketing and merchandising.
“Rhett has extensive retail and association management experience that will be very valuable to our members,” said FMI president and CEO Leslie Sarasin. “He is highly regarded within the industry for his knowledge of loss prevention issues, and we are excited to have him join FMI.”
Periscope introduces Flip Cover+Lights
RIDGEWOOD, N.J. Periscope has introduced an integrated reading light and deluxe cover for e-readers.
Periscope’s Flip Cover+Lights is available in two versions — one that’s compatible with both the Amazon Kindle 2 (6-inch screen) and Barnes & Noble Nook e-readers and a second larger version that is compatible with the Amazon Kindle DX e-reader.
The new Flip Cover+Lights are available at the following suggested retail prices: $49.95 for the Kindle 2/Nook version and $59.95 for the larger Kindle DX version.
“As the market for e-readers grows and expands at an explosive rate, so too does the demand for e-reader covers and reading lights,” said Periscope president Eric Fisherman. “Covers and lights are essential components of the e-reader package and neither is included with a basic e-reader purchase. What’s more, all current e-readers are standardized on a screen technology that is not back lit, which makes the purchase of a reading light mandatory if the product is to be enjoyed in a low light environment.”
Pfizer’s Xyntha-administering syringe gets FDA approval
NEW YORK The Food and Drug Administration has approved a prefilled dual-chamber syringe made by Pfizer for treating hemophilia, Pfizer said.
The FDA approved the syringe for administering the drug Xyntha (antihemophilic factor [recombinant]) for hemophilia A. The drug is used to prevent and control bleeding episodes in patients.
“The approval of the pre-filled dual-chamber syringe is an important milestone for hemophilia patients due to its innovative, convenient reconstitution system that eliminates the transfer step,” Pfizer VP marketing for specialty biologics Emil Andrusko said.